2025 ESC Guidelines for the management of myocarditis and pericarditis.
Schulz-Menger J. et al, (2025), Eur Heart J
First trimester maternal infections and offspring congenital heart defects: a meta-analysis.
Su H. et al, (2025), Eur Heart J
Reply: Reconsidering the Oncologic Implications of Antihypertensive Therapy.
Nazarzadeh M. and Rahimi K., (2025), JACC CardioOncol, 7
European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice.
Lauder L. et al, (2025), Nat Rev Cardiol
Refined selection of individuals for preventive cardiovascular disease treatment with a transformer-based risk model.
Rao S. et al, (2025), Lancet Digit Health
Blood Pressure Lowering and Risk of Cancer: Individual Participant-Level Data Meta-Analysis and Mendelian Randomization Studies.
Nazarzadeh M. et al, (2025), JACC CardioOncol
Identification of heart failure subtypes using transformer-based deep learning modelling: a population-based study of 379,108 individuals.
Fan Z. et al, (2025), EBioMedicine, 114
Lipid-lowering therapies for aortic stenosis: a drug-target Mendelian randomization study.
Ciofani JL. et al, (2025), Eur Heart J Cardiovasc Pharmacother, 11, 136 - 142
What Is New and Different in the 2024 European Society of Cardiology Guidelines for the Management of Elevated Blood Pressure and Hypertension?
McCarthy CP. et al, (2025), Hypertension, 82, 432 - 444
Cardiology training in crisis? A call to action from the Joint British Cardiovascular Societies.
Batty JA. et al, (2025), Heart, 111, 241 - 243
Age-Stratified Risk Categories for Cardiovascular Disease Prevention Therapies.
McCarthy CP. et al, (2024), JAMA Cardiol, 9, 1069 - 1070
[2024 ESC Guidelines for the management of elevated blood pressure and hypertension].
McEvoy JW. et al, (2024), G Ital Cardiol (Rome), 25, e1 - e107
RECOMED: A comprehensive pharmaceutical recommendation system.
Zomorodi M. et al, (2024), Artif Intell Med, 157
Temporal trends in cross-country inequalities of stroke and subtypes burden from 1990 to 2021: a secondary analysis of the global burden of disease study 2021.
Luo Z. et al, (2024), EClinicalMedicine, 76
2024 ESC Guidelines for the management of elevated blood pressure and hypertension.
McEvoy JW. et al, (2024), Eur Heart J
Providing healthcare under the threat of gang-violence: a survey of Haitian healthcare providers.
Belt RV. et al, (2024), Confl Health, 18
Emerging role of incretin-based therapy as first-line antihypertensives in obesity.
Rahimi K., (2024), Heart
Blood pressure management in type 2 diabetes: a review of recent evidence.
Wamil M. et al, (2024), Heart